Condition: Stroke · Sponsor: Spaulding Rehabilitation Hospital
The goal of this trial is to study if the concomitant administration of Telmisartan, Cilostazol IR (immediate release), and Metformin ER (extended release) can help stroke survivors make greater gains in movement and recovery during robot-assisted arm and hand rehabilitation.
This description comes directly from the study's public registry record.
Madison Costa, OT · 617-952-6388 · mcosta11@mgb.org
Erin Foley, OT · 617-952-6388 · efoley14@mgb.org
Always discuss trial participation with your own doctor first.
| Spaulding Rehabilitation Hospital | Charlestown, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07588932